Cardium Therapeutics Inc

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to partnering, commercialization and other economic monetizations.

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to partnering, commercialization and other economic monetizations.

Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical...

Top 50 Publicly Traded Biomed/Biotech Firms;79 Public Companies;85 Public Companies;86 Public Companies